Loading company…
Nuohong Huikang develops cell culture products and reagents for cell and gene therapy research and production.
Founded in 2023 and based in Chengdu, China, Nuohong Huikang develops cell biology and cell and gene therapy reagents. Its products include culture media, serum substitutes and systems for MSC, NK, organoid and iPSC applications. In May 2026, it raised approximately CNY 100 million in Series A funding to expand GMP production in Luzhou, establish a Yangtze River Delta subsidiary, develop products and promote them globally.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in